Kelfred Holdings Limited AI Stock Analysis
Want to see HK:1134 full AI Analyst Report?
Kelfred Holdings Limited (1134) AI Stock Analysis
Kelfred Holdings Limited
(HKEX:1134)
The score is driven primarily by improving fundamentals—strong recent revenue growth, better cash generation, and low leverage—offset by continued net losses and negative shareholder returns. Technicals are soft (below key moving averages with negative MACD), and valuation support is limited due to the negative P/E.
Kelfred Holdings Limited (1134) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 102.50M
- Dividend Yield
- ―
- Average Volume (3M)
- 628.98K
- Price to Earnings (P/E)
- -4.6
- Beta (1Y)
- -0.20
- Revenue Growth
- -4.28%
- EPS Growth
- -58.51%
- Country
- Hong Kong
- Employees
- 768
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Instruments & Supplies
Kelfred Holdings Limited Business Overview & Revenue Model
Company Description
Kelfred Holdings Limited functions as an investment holding entity primarily engaged in the creation and sale of eyewear. The firm produces a diverse array of spectacle frames and sunglasses, largely leveraging original design manufacturing (ODM) and...
Kelfred Holdings Limited Financial Statement Overview
Summary
Strong revenue rebound and materially improved operating/free cash flow, supported by a low-debt balance sheet. However, the company remains loss-making with negative operating and net margins and meaningfully negative ROE, keeping the score in the mid-range.
Income Statement
46NeutralBalance Sheet
74PositiveCash Flow
68Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 477.33M | 500.25M | 453.58M | 393.28M | 465.43M | 434.73M |
| Gross Profit | 51.08M | 59.31M | 44.66M | 56.98M | 76.02M | 68.44M |
| EBITDA | -12.33M | 4.06M | -11.56M | 14.24M | 21.11M | 13.11M |
| Net Income | -22.35M | -15.12M | -21.63M | 1.39M | 9.18M | -2.14M |
Balance Sheet | ||||||
| Total Assets | 257.30M | 282.83M | 282.93M | 264.00M | 251.90M | 268.13M |
| Cash, Cash Equivalents and Short-Term Investments | 29.88M | 48.00M | 27.81M | 20.33M | 46.40M | 36.93M |
| Total Debt | 7.56M | 8.46M | 12.56M | 15.22M | 2.01M | 4.00M |
| Total Liabilities | 115.61M | 134.35M | 126.49M | 80.81M | 65.32M | 81.80M |
| Stockholders Equity | 141.86M | 148.52M | 156.43M | 183.19M | 186.57M | 186.33M |
Cash Flow | ||||||
| Free Cash Flow | 4.02M | 23.32M | 12.54M | -20.32M | 14.59M | -27.01M |
| Operating Cash Flow | 7.03M | 25.75M | 17.49M | -4.63M | 19.28M | -21.87M |
| Investing Cash Flow | -3.54M | -2.55M | -4.80M | -16.61M | -5.21M | -5.73M |
| Financing Cash Flow | -3.72M | -3.51M | -5.03M | -4.25M | -3.65M | -11.74M |
Kelfred Holdings Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1134, the sentiment is Negative. The current price of 0.20 is above the 20-day moving average (MA) of 0.20, below the 50-day MA of 0.21, and below the 200-day MA of 0.28, indicating a bearish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 44.90 is Neutral, neither overbought nor oversold. The STOCH value of 27.27 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1134.
Kelfred Holdings Limited Peers Comparison
Overall Rating
HK:227673Outperform
HK:113455Neutral
HK:090744Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 73Outperform | HKD 17.85B | 24.92 | 17.68% | 1.29% | 8.36% | 14.91% | |
| 55Neutral | HKD 102.50M | -4.59 | -15.40% | ― | -4.28% | -58.51% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 44Neutral | HKD 53.24M | -87.14 | -36.35% | ― | 1140.27% | 96.98% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:1134 | Kelfred Holdings Limited | 0.20 | -0.12 | -36.92% | |
| HK:0907 | Elegance Optical International Holdings Limited | 0.06 | 0.00 | 0.00% | |
| HK:2276 | Shanghai Conant Optical Co. Ltd. Class H | 35.82 | -12.17 | -25.36% |
Kelfred Holdings Limited Corporate Events
Kelfred Holdings Reshapes Board With Director Resignations and New INED Appointment
Kelfred Holdings Limited announced changes to its board, including the resignation of executive director Mr. Kwok Kwan Fai and independent non-executive director Mr. Chu Kin Ming with effect from 30 October 2026. Both departing directors cited person...
Kelfred Holdings Sets Out Board and Committee Structure
Kelfred Holdings Limited has announced the current composition of its board of directors, detailing the roles of executive, non-executive and independent non-executive members and confirming its adherence to established governance practices.The Board...
Kelfred Holdings Appoints New Company Secretary and Authorised Representative
Kelfred Holdings Limited has announced a change in key governance roles, with company secretary and authorised representative Mr. Choi Chun Wai resigning effective 1 September 2026. The board noted that Mr. Choi has no disagreement with directors and...
Kelfred Holdings Posts Unaudited Interim Results for First Half of 2026
Kelfred Holdings Limited has released its unaudited condensed consolidated interim results for the six months ended 30 June 2026, with the full interim report prepared in compliance with Hong Kong listing requirements. The printed report will be sent...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 17, 2026
